Neonatal developmental and epileptic encephalopathy with movement disorders and arthrogryposis: A case report with a novel missense variant of SCN1A.

Arthrogryposis multiplex congenita Early infantile SCN1A epileptic encephalopathy Early infantile developmental and epileptic encephalopathy with movement disorders Neonatal developmental and epileptic encephalopathy with movement disorders and arthrogryposis SCN1A Scoliosis

Journal

Brain & development
ISSN: 1872-7131
Titre abrégé: Brain Dev
Pays: Netherlands
ID NLM: 7909235

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 15 11 2022
revised: 28 06 2023
accepted: 29 06 2023
medline: 28 8 2023
pubmed: 14 7 2023
entrez: 13 7 2023
Statut: ppublish

Résumé

Variants of SCN1A represent the archetypal channelopathy associated with several epilepsy syndromes. The clinical phenotypes have recently expanded from Dravet syndrome. CASE REPORT: We present a female patient with the de novo SCN1A missense variant, c.5340G > A (p. Met1780Ile). The patient had various clinical features with neonatal onset SCN1A epileptic encephalopathy, arthrogryposis multiplex congenita, thoracic hypoplasia, thoracic scoliosis, and hyperekplexia. CONCLUSION: Our findings are compatible with neonatal developmental and epileptic encephalopathy with movement disorders and arthrogryposis; the most severe phenotype probably caused by gain-of-function variant of SCN1A. The efficacy of sodium channel blocker was also discussed. Further exploration of the phenotype-genotype relationship of SCN1A variants may lead to better pharmacological treatments and family guidance.

Identifiants

pubmed: 37442734
pii: S0387-7604(23)00110-9
doi: 10.1016/j.braindev.2023.06.009
pii:
doi:

Substances chimiques

NAV1.1 Voltage-Gated Sodium Channel 0
SCN1A protein, human 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

505-511

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yukimune Okubo (Y)

Department of Pediatric Neurology, Miyagi Children's Hospital, Sendai 989-3126, Japan. Electronic address: yokubom@yahoo.co.jp.

Moriei Shibuya (M)

Department of Pediatric Neurology, Miyagi Children's Hospital, Sendai 989-3126, Japan.

Haruhiko Nakamura (H)

Department of Pediatric Neurology, Miyagi Children's Hospital, Sendai 989-3126, Japan.

Aritomo Kawashima (A)

Department of Pediatric Neurology, Miyagi Children's Hospital, Sendai 989-3126, Japan.

Kaori Kodama (K)

Department of Pediatric Neurology, Miyagi Children's Hospital, Sendai 989-3126, Japan.

Wakaba Endo (W)

Department of Pediatric Neurology, Miyagi Children's Hospital, Sendai 989-3126, Japan.

Takehiko Inui (T)

Department of Pediatric Neurology, Miyagi Children's Hospital, Sendai 989-3126, Japan.

Noriko Togashi (N)

Department of Pediatric Neurology, Miyagi Children's Hospital, Sendai 989-3126, Japan.

Yu Aihara (Y)

Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan.

Matsuyuki Shirota (M)

Division of Interdisciplinary Medical Science, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Ryo Funayama (R)

Division of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Tetsuya Niihori (T)

Department of Medical Genetics, Tohoku University Graduate School of Medicine, Sendai, Japan.

Atsushi Fujita (A)

Department of Human Genetics, Yokohama City University Graduate School of Medicine.

Keiko Nakayama (K)

Division of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yoko Aoki (Y)

Department of Medical Genetics, Tohoku University Graduate School of Medicine, Sendai, Japan.

Naomichi Matsumoto (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine.

Shigeo Kure (S)

Department of Pediatric Neurology, Miyagi Children's Hospital, Sendai 989-3126, Japan; Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan.

Atsuo Kikuchi (A)

Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan.

Kazuhiro Haginoya (K)

Department of Pediatric Neurology, Miyagi Children's Hospital, Sendai 989-3126, Japan. Electronic address: khaginoya@kha.biglobe.ne.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH